XpressO MoCA
MoCA Cognition

Clinical
Trials

Recruiting Clinical Trials for Alzheimer's Disease
Currently recruiting Alzheimer's Disease clinical trials listed here are retrieved from clinicaltrials.gov
Testing the Effects of a Text Message Caregiver Support Intervention for Latinos
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
Nicotinic Acid for the Treatment of Alzheimer's Disease
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Assessing the Impact of DAy Programs on Individuals Living with Dementia and Their Family/friend Caregivers
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
An Objective Assessment Tool for Evaluating Functioning in Older Adults
MoCA XPRESSO
Available in 8 languages
English, French, Spanish, German, Italian, Japanese, Greek & Arabic
download xpresso
Download the app from both Apple App Store and Google Play Store and test your memory
Download XpressO from Apple App StoreDownload XpressO from Google Play
Login
Forgot password
Email address
Submit
Your browser window is too small

Your browser window isn't big enough to perform the XpressO MoCA test.

Please resize your browser window to make room for the test.

If you are not able to make the window bigger, you can also perform the test using our mobile app. It can be downloaded here:

This message will disappear as soon as the browser window is large enough.

Loading,
one moment
please...

Loading,
one moment
please...

Delete account

Are you sure that you want to delete your account? All test results will be lost.

Cancel
Yes
Your request has been received

Your delete request has been received. Our support team will delete your account within the next 48 hours. We thank you for placing your trust in us and using our services.

Ok